Cumberland PharmaceuticalsCPIX
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 31 institutions reported holding Cumberland Pharmaceuticals (CPIX) in their 13F filings, down 2 from Q1 2025. 6 opened new positions and 8 sold out. The largest holders were Millennium Management ($2.6M), Ikarian Capital, LLC ($2.0M) and Renaissance Technologies ($1.7M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cumberland Pharmaceuticals
- CUSIP
- 230770109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $185K |
| Exits | 8 | $2.0M |
All 13F filers, Q1 2025 → Q2 2025: 151,188 shares bought and 749,932 shares sold, net −598,744 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Millennium Management | 0.00% | Reduce -4.2% | 775,976 | $2.6M |
| Ikarian Capital, LLC | 0.66% | Reduce -19.5% | 595,932 | $2.0M |
| Renaissance Technologies | 0.00% | Reduce -1.7% | 494,963 | $1.7M |
| Vanguard Group Inc. | 0.00% | Reduce -1.1% | 411,786 | $1.4M |
| Dimensional Fund Advisors LP | 0.00% | Add +0.3% | 252,889 | $847K |
| J. Goldman & Co LP | 0.02% | Reduce -8.6% | 220,707 | $739K |
| Bridgeway Capital Management, LLC | 0.01% | Add +2.3% | 188,355 | $631K |
| Boothbay Fund Management, LLC | 0.02% | Reduce -19.5% | 180,229 | $604K |
| Geode Capital Management, LLC | 0.00% | Add +1.2% | 100,237 | $336K |
| Citadel Advisors | 0.00% | Add +188.2% | 74,406 | $249K |
| Bank of New York Mellon Corp | 0.00% | No change | 72,513 | $243K |
| BlackRock, Inc. | 0.00% | Add +56.7% | 51,168 | $171K |
| Acadian Asset Management LLC | 0.00% | Reduce -9.9% | 44,288 | $148K |
| State Street Corp. | 0.00% | No change | 33,700 | $113K |
| Heron Bay Capital Management | 0.02% | New | 33,251 | $111K |
| Two Sigma Investments, LP | 0.00% | Add +41.8% | 32,265 | $108K |
| Northern Trust Corp. | 0.00% | No change | 19,603 | $66K |
| Cresset Asset Management, LLC | 0.00% | Reduce -7.5% | 18,475 | $62K |
| Simplex Trading, LLC | 0.00% | Reduce -25.6% | 14,218 | $47K |
| Morgan Stanley | 0.00% | Add +366.1% | 12,398 | $42K |
| Susquehanna International Group, LLP | 0.00% | Reduce -60.2% | 11,527 | $39K |
| &partners | 0.00% | No change | 11,000 | $37K |
| XTX Topco Ltd | 0.00% | New | 10,280 | $34K |
| UBS Group AG | 0.00% | Add +65.2% | 8,818 | $30K |
| Group One Trading LLC | 0.00% | New | 8,222 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,102 | $7K |
| NewEdge Advisors, LLC | 0.00% | New | 1,428 | $5K |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 437 | $1K |
| Bank of America Corp. | 0.00% | Add +38.2% | 94 | $315 |
| Barclays PLC | 0.00% | New | 2 | $7 |
| Huntington National Bank | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is CPIX's weight in each manager's 13F, not the share of Cumberland Pharmaceuticals the manager owns.